| Literature DB >> 32356024 |
Yasuhiro Wada1,2, Ryoji Kushima3, Masaaki Kodama1, Masahide Fukuda1, Kensuke Fukuda1, Kazuhisa Okamoto1, Ryo Ogawa1, Kazuhiro Mizukami1, Tadayoshi Okimoto1, Kazunari Murakami1.
Abstract
Pyloric metaplasia (PM) and pseudopyloric metaplasia (PPM) are metaplastic changes resulting in pyloric-type glands in the gastric oxyntic mucosa that mainly occur in chronic gastritis caused by Helicobacter pylori (H. pylori) infection. Focusing on PM and PPM, we classified the histological changes in gastric mucosa according to the Updated Sydney System, using 314 biopsy specimens of gastric greater curvature of the middle body before H. pylori eradication (HPE). Next, the numbers of PM and PPM glands were counted in 47 specimens, and subjects were followed up over 10 years after HPE. PPM was recognized jointly with inflammation, activity, atrophy, and intestinal metaplasia, but PM was recognized more frequently than PPM as atrophy and intestinal metaplasia progressed. Both PM and PPM regressed significantly within 6 years after HPE. Additionally, we demonstrated that PM and PPM are not always coincident with spasmolytic polypeptide-expressing metaplasia (SPEM). In conclusion, PM and PPM are considered different modulations of the same line of differentiation, which are both reversible, with PM potentially emerging from PPM upon progression.Entities:
Keywords: Helicobacter pylori; Pseudopyloric metaplasia; Pyloric metaplasia; Spasmolytic polypeptide-expressing metaplasia (SPEM)
Year: 2020 PMID: 32356024 DOI: 10.1007/s00428-020-02805-9
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064